This activity has been updated to include discussion on Extended Release/Long Acting (ER/LA) opioids based on the full FDA REMS blueprint, nature of pain & pain management, Immediate Release/Short Acting opioids, & the CDC Guidelines for prescribing opioids for chronic pain.
NP/PA 24-Hour Waiver Course for prescribing Buprenorphine
NP/PA 24-Hour Waiver Course - This course satisfies the 24-hour continuing education training requirement to allow practitioners to apply for a waiver to prescribe buprenorphine to their patients with opioid use disorders.
If you have already completed the first 8 hours of training you can complete the additional 16 hours in Part II - NP/PA 16-Hour Waiver Course.
Details are available in the activity description and specific instructions to complete this activity are provided when you add it to your Products page (Register).
